This is precisely why research like this is valuable. We are gathering and discussing the available information BEFORE a price catalyst.
since we are now entirely across Nanose and Brainchip, the clinical trials and the patents, we can all make an informed decision as to whether the risk of investing in a covid breathalyzer is worth the potential upside if the product becomes the defacto standard for testing for covid across the world.
there are two options:
1) stick your hand in the sand be ignorant to the information about the Nanose and Brainchip device
2) fully understand the technology, patents, trials, research and progress and cross your fingers the device gets approved and distributed globally
according to the information we know, based on data provided by Nanose themselves, Brainchips SNN DOES work well enough.
as to the FDA approval of the device or any on going clinical trials, that is unknown.
- Forums
- ASX - By Stock
- NANOSE & SNIFFPHONE
This is precisely why research like this is valuable. We are...
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $451.3M |
Open | High | Low | Value | Volume |
23.0¢ | 24.0¢ | 21.5¢ | $2.863M | 12.69M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 136498 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 444756 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 86498 | 0.230 |
3 | 155000 | 0.225 |
16 | 439886 | 0.220 |
14 | 751341 | 0.215 |
35 | 871743 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 360988 | 11 |
0.240 | 791244 | 17 |
0.245 | 612347 | 15 |
0.250 | 151787 | 5 |
0.255 | 132485 | 7 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
BRN (ASX) Chart |